Philips Opens its First Co-creation Center to Support Care Organizations with the Transformation to New Models for Connected Health Enabled by Digital Technologies

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) has announced the opening of its first HealthSuite Labs co-creation center at High Tech Campus Eindhoven, the Netherlands. The new facility provides an environment to spur digital healthcare innovation and supports healthcare organizations in the transformation towards connected and more value-based, patient-centered care models. Healthcare directors and general practitioners can work together in multidisciplinary teams with patients as well as clinical, design, digital and business experts on the co-creation and implementation of integrated care solutions to enhance self-management and continuity of care for patients.

Following the launch of its facility in the Netherlands, Philips will be rolling out the HealthSuite Lab co-creation centers in other locations globally. Dedicated centers are already planned in Asia and the US to support customers in these regions.

Philips also announced the new collaboration with the regional care network Zorgnetwerk Midden-Brabant (ZMBR), which represents the Elisabeth-TweeSteden Hospital as well as general practitioners, home care nurses, dietitians and patients in the region. Through the HealthSuite Labs co-creation center, the organizations are developing a new regional connected health model for people living with type-2 diabetes - the first such model in the Netherlands.

Under this model, people will be given access to and control over their own actionable health data. They will also be encouraged to set realistic personal goals to support them in making decisions that are important to their health and care management. In this way, the project aims to enhance self-management for patients with diabetes and improve their quality of life. Other important goals are to decrease visits to caregivers, increase treatment and medication loyalty. This collaboration is an example of also how other care providers can co-create in the center to solve the complex challenges that healthcare systems face.

"Most of today's healthcare budget goes to the fast-growing population of people living with chronic illness," said Jeroen Tas, CEO Healthcare Informatics Solutions and Services, Philips. "The pressure on global healthcare systems is increasing, requiring them to find alternative ways of care delivery. At the same time, people want to be more involved in managing their own health.

Together, these factors are shifting healthcare's focus from traditional hospital-based, treat-when-sick (acute) models towards prevention and continuity of care in or near one's home. Our HealthSuite Labs co-creation center will help care providers speed up the development and implementation of new integrated, connected and patient-centric healthcare delivery solutions that enable these new models."

"We want patients to be more empowered to manage their condition and their health," said Veronique Holtmaat, Director Zorgnetwerk Midden-Brabant. "For this we need to improve the collection and exchange of data that various professionals and patients collect and make that data relevant and actionable. By working with Philips in the HealthSuite Labs co-creation center, we gain access to a wealth of know-how plus insight from other stakeholders across the care continuum and can set the next steps in creating truly collaborative and patient-centric care delivery."

Drawing on the effective collection, analysis and sharing of health data, the solutions developed in the HealthSuite Lab co-creation center will be enabled by the HealthSuite Digital Platform, Philips' secure cloud-based IT infrastructure. Philips has collaborated with the Radboudumc REshape Center for their vital contribution to a patient-centric approach in the HealthSuite Labs innovation process.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 106,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

About Zorg Netwerk Midden-Brabant
The regional care network Zorgnetwerk Midden-Brabant is a unique collaboration network of care providers in the central Brabant region in the south of the Netherlands. Together the care providers strive for high-quality, aligned and accessible care and treatment of patients and citizens in the region. The purpose of the diabetes program is to optimize patient care through the development of care-related protocols and collaborative processes. Further, the goal is to innovate the care delivery process together. The regional care network Zorgnetwerk Midden-Brabant focuses on patient self-management and the patient being an active member of society.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

AI-Based Chatbot Created for Bioimage An…

Scientists from Universidad Carlos III de Madrid (UC3M), together with a research team from Ericsson and the KTH Royal Institute of Technology in Sweden, have developed an artificial intelligence-based software...

Analyzing Multiple Mammograms Improves B…

A new study from Washington University School of Medicine in St. Louis describes an innovative method of analyzing mammograms that significantly improves the accuracy of predicting the risk of breast...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...